deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT01092195

Gardasil Vaccination in Post Stem Cell Transplant Patients

A Phase I Trial of Safety and Immunogenicity of Gardasil Vaccination Post Stem Cell Transplantation in Patients With and Without Immunosuppression

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Gardasil Vaccine Immunogenicity Stem Cell Transplant
Interventions Gardasil
Updated 14 times since 2017 Last updated: Jul 25, 2019 Started: Jun 2, 2010 Primary completion: Jul 19, 2016 Completion: Jul 19, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Gardasil Vaccine and Immunogenicity and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 14 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Apr 2019 · 7 months · monthly snapshot~Apr 2019 – ~Aug 2019 · 4 months · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1

▶ Show 9 earlier versions

  1. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE1

  2. Aug 2019 — Sep 2019 [monthly]

    Completed PHASE1

  3. Apr 2019 — Aug 2019 [monthly]

    Completed PHASE1

  4. Sep 2018 — Apr 2019 [monthly]

    Completed PHASE1

  5. Aug 2018 — Sep 2018 [monthly]

    Completed PHASE1

  6. Jul 2018 — Aug 2018 [monthly]

    Completed PHASE1

  7. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE1

  8. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  9. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations